$\backslash$table$[[$$ millions,$2019],[$Current assets$],[$Cash and cash equivalents,$$4,393],[$Investments$,5,459],[$Accounts receivable, net,$6,222],[$Inventories$,$ net,$3,753],[$Other current assets,$2,144],[$Total current assets,$21,967],[$Property$,$ plant, and equipment, net,$4,675],[$Goodwill$,39,959],[$Other intangible assets, net,$20,560],[$Tax assets,$1,519],[$Other assets,$1,014],[$Total assets,$$89,694],[$Current liabilities$],[$Current debt obligations,$$838],[$Accounts payable,$1,953],[$Accrued compensation,$2,189],[$Accrued income taxes,$567],[$Other accrued expenses,$2,92=],[$Total current liabilities,$8,472],[$Long$-$term debt,$24,486],[$Accrued compensation and retirement benefits,$1,651],[$Accrued income taxes,$2,838],[$Deferred tax liabilities,$1,278],[$Other liabilities,$757],[$Total liabilities,$39,482],[$Shareholders$\text{'}$ equity$],[$Ordinary shares,$0],[$Additional paid$-$in capital,$26,532],[$Retained earnings,$26,270],[$Accumulated other comprehensive loss,$(2,711)],[$Total shareholders' equity,$50,091],[$Noncontrolling interests,$121],[$Total equity,$50,212],[$Total liabilities and equity,$$89,694]]$ Prepare a forecast of the FY$2020$ statement of cash flows using the provided financial information and following assumptions. with $-$

Note: Use negative signs with answers, when appropriate.

$\backslash$table$[[$Income statement assumptions,$],[$Net sales increase,$8\%,$growth$],[$Cost of products sold,$30\mathrm{.}0\%,$of net sales$],[$Research and development expense,$7\mathrm{.}6\%,$of net sales$],[$Selling$,$ general, and administrative expense,$34\mathrm{.}1\%,$of net sales$],[$Amortization of intangible assets,$5\mathrm{.}8\%,$of net sales$],[$Restructuring charges, net,$75\%,$of $2019$ restructuring expense$],[$Certain litigation charges, net,$$150,$million$],[$Other operating expense, net,,No change in $ amount$],[$Other nonoperating income, net,,No change in $ amount$],[$Interest expense,,No change in $ amount$],[$Income tax provision,$15\%,$of pretax income$],[$Income attributable to noncontrolling interests,,No change in $ amount$]]$

$\backslash$table$[[$Balance sheet assumptions,No change$],[$Investments$,,$No$],[$Accounts receivable, less allowance,$20\mathrm{.}4\%,$of net sales$],[$Inventories$,$ net,$12\mathrm{.}3\%,$of net sales$],[$Other current assets,$7\%,$of net sales$],[$Goodwill$,,$No change$],[$Tax assets,$5\%,$of net sales$],[$Other assets,$3\mathrm{.}3\%,$of net sales$],[$Accounts payable,$6\mathrm{.}4\%,$of net sales$],[$Accrued compensation $($current liability$),7\mathrm{.}2\%,$of net sales$],[$Accrued compensation and retirement benefits $($noncurrent liability$),,$No change$],[$Accrued income taxes $($current liability$),1\mathrm{.}9\%,$of net sales$],[$Other accrued expenses,$9\mathrm{.}6\%,$of net sales$],[$Accrued income taxes $($noncurrent liability$),9\mathrm{.}3\%,$of net sales$],[$Deferred tax liabilities,$4\mathrm{.}2\%,$of net sales$],[$Other liabilities,$2\mathrm{.}5\%,$of net sales$],[$Ordinary shares,,No change$],[$Accumulated other comprehensive loss,,No change$],[$Net income attributable to noncontrolling interest,$$19,$million$]]\backslash$table$[[$Balance sheet assumptions$],[$Investments$,,$No change$],[$Accounts receivable, less allowance,$20\mathrm{.}4\%,$of net sales$],[$Inventories$,$ net,$12\mathrm{.}3\%,$of net sales$],[$Other current assets,$7\%,$of net sales$],[$Goodwill$,,$No change$],[$Tax assets,$5\%,$of net sales$],[$Other assets,$3\mathrm{.}3\%,$of net sales$],[$Accounts payable,$6\mathrm{.}4\%,$of net sales$],[$Accrued compensation $($current liability$),7\mathrm{.}2\%,$of net sales$],[$Accrued compensation and retirement benefits $($noncurrent liability$),,$No change$],[$Accrued income taxes $($current liability$),1\mathrm{.}9\%,$of net sales$],[$Other accrued expenses,$9\mathrm{.}6\%,$of net sales$],[$Accrued income taxes $($noncurrent liability$),9\mathrm{.}3\%,$of net sales$],[$Deferred tax liabilities,$4\mathrm{.}2\%,$of net sales$],[$Other liabilities,$2\mathrm{.}5\%,$of net sales$],[$Ordinary shares,,No change$],[$Accumulated other comprehensive loss,,No change$],[$Net income attributable to noncontrolling interest,$$19,$million$],[$Dividends in FY$2020,$$$2,853,$million$],[$CAPEX in FY$2019,$$$1,134,$$million, forecast CAPEX at historic $\%$ of net sales$],[$Depreciation expense in FY$2020,$$$950,$million$],[$Amortization expense in FY$2020,$$$1,914,$million$],[$Debt due in FY$2020,$$$838,$million$],[$Debt due in FY$2021,$$$2,058,$million$]]\backslash$table$[[\backslash$table$[[$Medtronic PLC$],[$Forecasted Statement of Cash Flows$],[$For year ended$],[($ $ millions$)]],2020],[$Net income $($before non$-$controlling interest$),$$$],[$Add: Depreciation,$950$vv$],[$Add: Amortization,$1914>],[$Change in Accounts receivable,x$],[$Change in Inventories, net,x$],[$Change in Other current assets,x$],[$Change in Tax assets,x$],[$Change in Other assets,x$],[$Change in Accounts payable,$159\mathrm{.}1$vv$],[$Change in Accrued compensation,$187\mathrm{.}11$vv$],[$Change in Accrued income taxes,$60\mathrm{.}03$vv$],[$Change in Other accrued expenses,$243\mathrm{.}15$vv$],[$Change in Accrued income taxes,$231\mathrm{.}14$vv$],[$Change in Deferred tax liabilities,$108\mathrm{.}07$vv$],[$Change in Other liabilities,$68\mathrm{.}04$vv$],[$Net cash from operating activities,x$],[$Capital expenditures,x$],[$Net cash from investing activities,x$],[$Dividends$,-285$V$],[$Change in current debt obligations,$1220$vv$],[$Change in L$-$T Debt,x$],[$Net cash from financing activities,x$],[$Net change in cash,x$],[$Beginning cash,$4393$vv$],[$Ending cash,$\backslash$bar $($$$)]]$